Background: Type 2 diabetes mellitus (T2DM) is a chronic progressive metabolic disorder
and liraglutide is one of the glucagon-like peptide-1 (GLP-1) agonists that are used
to decrease glucose levels in the blood and help in weight loss in patients with T2DM.
Bibliometric analysis is one of the most common statistical methods used to evaluate
the credibility, quality, and impact of scholarly work.
To read this article in full you will need to make a payment
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:
Subscribe to Metabolism - Clinical and ExperimentalAlready a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
